ReviewJournal of oral biology and craniofacial research
Mucin dysregulation in salivary gland tumorigenesis: Diagnostic, prognostic, and therapeutic insights: A systematic review & meta-analysis.
Review in Journal of oral biology and craniofacial research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Salivary gland tumors (SGTs) comprise a heterogeneous group of neoplasms with overlapping histopathological features, making diagnosis and classification challenging Mucins(MUCs) are high molecular weight glycoproteins involved in epithelial differentiation and tumorigenesis which have emerged as potential biomarkers in salivary gland pathology. Methodology: A thorough review and meta-analysis were conducted across PubMed, Scopus, Web of Science, and Embase until February 2025 to elucidate the diagnostic, prognostic, and therapeutic significance of mucin differential expression in benign and malignant SGTs. Result: Twenty-nine articles encompassing 1657 salivary gland cases were included. Data on mucins, their localization, and expression pattern using immunohistochemistry, RT-PCR, or ELISA were evaluated. MUC1 and MUC4 were predominantly expressed in PA and MEC, with MUC1 associated with high-grade MECs and recurrence in PA. MUC4 showed higher expression in low-grade MECs and was diagnostically specific for secretory carcinoma. MUC1 showed high expression in both MEC and PA, but the pooled odds ratios [MEC: OR = 2.23; PA: OR = 0.35] were statistically non-significant (p > 0.05), with moderate heterogeneity (I Conclusion: Mucins demonstrate differential expression across salivary gland tumors and may complement histopathological evaluation. However, the current quantitative evidence remains insufficient to support their use as standalone diagnostic biomarkers due to limited specificity and considerable uncertainty in pooled estimates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.